SECUKINUMAB

Secukinumab 300 mg/2 mL injection, 2 mL pen device

SECUKINUMAB (14972B)

Secukinumab 300 mg/2 mL injection, 2 mL pen device
14972B
Body System:
Manner of administration:Injection
General Schedule
Authority Required

Restriction

Indication: Severe chronic plaque psoriasis
Treatment phase: Continuing treatment, Whole body

Restriction

Indication: Severe chronic plaque psoriasis
Treatment phase: Continuing treatment, Face, hand, foot

Restriction

Indication: Severe chronic plaque psoriasis
Treatment phase: Balance of supply - Continuing treatment, Whole body or Continuing treatment, Face, hand, foot
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 5 DPMQ: $1,336.27 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Cosentyx